SeqWright, Eli Lilly to Use NimbleGen Capture, 454 Sequencing to Study Psychiatric Diseases
August 04, 2009
SeqWright, Eli Lilly to Use NimbleGen Capture, 454 Sequencing to Study Psychiatric Diseases
Under the collaboration, SeqWright, a sequencing service provider based in Houston, will use NimbleGen's sequence capture technology and 454's sequencing platform to selectively enrich and sequence approximately 40 megabases of the human genome.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.